Zimmer Biomet Holdings (ZBH) Divestments (2021 - 2022)

Zimmer Biomet Holdings (ZBH) recorded quarterly Divestments of -$7.2 million in Q1 2022, up 67.57% quarter-over-quarter from -$22.2 million in Q4 2021, and up 49.3% on a YoY basis from -$4.8 million in Q1 2021.

Zimmer Biomet Holdings (ZBH) Divestments (2021 - 2022) Analysis & Trends

Zimmer Biomet Holdings' Divestments history runs 2 years deep, the most recent figure standing at -$7.2 million for Q1 2022.

  • In Q1 2022, Divestments rose 49.3% year-over-year to -$7.2 million; the TTM figure through Dec 2022 stood at -$7.2 million (up 88.06% YoY), while the FY2022 annual figure was -$7.2 million, up 88.06% from the prior year.
  • Divestments was -$7.2 million for Q1 2022 at Zimmer Biomet Holdings, up from -$22.2 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of -$7.2 million in Q1 2022 to a low of -$22.2 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.37 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2022 -7.20 Mn
Dec 31, 2021 -22.20 Mn
Sep 30, 2021 -12.90 Mn
Jun 30, 2021 -11.00 Mn
Mar 31, 2021 -14.20 Mn